Randomised, double-blind trial on the value of tapered discontinuation of clopidogrel maintenance therapy after drug-eluting stent implantation

Risk of Stent Thrombosis Among Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Second-Generation Drug-Eluting Stents

(2013) Tomohisa Tada et al.   JACC-Cardiovascular Interventions

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study

(2013) Roxana Mehran et al.   LANCET

Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study

(2012) M. Charlot et al.   EUROPEAN HEART JOURNAL

Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials

(2012) Salvatore Cassese et al.   EUROPEAN HEART JOURNAL

A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents

(2012) Dietmar Trenk et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

In-Stent Neoatherosclerosis

(2012) Seung-Jung Park et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Discontinuation of long term clopidogrel therapy induces platelet rebound hyperaggregability between 2 and 6 weeks post cessation

(2011) Philipp Diehl et al.   Clinical Research in Cardiology

Effect of clopidogrel withdrawal on platelet reactivity and vascular inflammatory biomarkers 1 year after drug-eluting stent implantation: results of the prospective, single-centre CESSATION study

(2011) N. Sambu et al.   HEART

Will We Ever Know the Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation?⁎⁎Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Cardiology.

(2011) Adnan Kastrati et al.   JACC-Cardiovascular Interventions

Abrupt Cessation of One-Year Clopidogrel Treatment Is Not Associated With Thrombotic Events

(2011) Nina Djukanovic et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Clopidogrel tapering as a strategy to attenuate platelet rebound phenomenon in patients with bare-metal stents

(2011) Idit Yedidya et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Absence of "rebound" platelet hyperreactivity following cessation of prasugrel

(2011) Ying G. Li et al.   THROMBOSIS AND HAEMOSTASIS

The Platelet Activity After Clopidogrel Termination (PACT) Study

(2010) Andrew L. Frelinger et al.   Circulation-Cardiovascular Interventions

Adverse Events After Stopping Clopidogrel in Post–Acute Coronary Syndrome Patients

(2010) P. Michael Ho et al.  

Patients With Previous Definite Stent Thrombosis Have a Reduced Antiplatelet Effect of Aspirin and a Larger Fraction of Immature Platelets

(2010) Morten Würtz et al.   JACC-Cardiovascular Interventions

A Double-Blind, Randomized Study on Prevention and Existence of a Rebound Phenomenon of Platelets After Cessation of Clopidogrel Treatment

(2010) Dirk Sibbing et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Beware of being caught on the rebound

(2010) M. LORDKIPANIDZÉ et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Clopidogrel discontinuation and platelet reactivity following coronary stenting

(2010) D. MYLOTTE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Clopidogrel withdrawal: Is there a “rebound” phenomenon?

(2010) Nalyaka Sambu et al.   THROMBOSIS AND HAEMOSTASIS

TCT-471: Is There a Platelet Rebound Effect to Stopping Clopidogrel ?

(2009)   AMERICAN JOURNAL OF CARDIOLOGY

Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period

(2009) S. Schulz et al.   EUROPEAN HEART JOURNAL

Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label study

(2009) Joanna J. Wykrzykowska et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Benefit of Clopidogrel for Acute Coronary Syndrome and Percutaneous Coronary Interventions in Doubt Due to Rebound Adverse Events

(2008) David K. Cundiff   AMERICAN JOURNAL OF CARDIOLOGY

Incidence of Death and Acute Myocardial Infarction Associated With Stopping Clopidogrel After Acute Coronary Syndrome

(2008) P. Michael Ho   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial

(2006) V. L. SEREBRUANY et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE